Showing results (1501-1510 of 9,040) with videos related to

Sort By:
Pageof 904
Vision Research|January 1, 1990
Distributions of choline acetyltransferase and acetylcholinesterase activities in the retinal layers of pigeon red and yellow fieldsL E White, C D Ross, D A Godfrey
Electrophoresis|March 25, 2010
Microfluidic cell arrays for metabolic monitoring of stimulated cardiomyocytesWei Cheng, Norbert Klauke, Godfrey Smith, et al.
International Journal of Environmental Research and Public Health|March 29, 2023
Personalised and Sustainable IEQ Monitoring: Use of Multi-Modal and Pervasive TechnologiesGraham Coulby, Adrian K Clear, Oliver Jones, et al.
Maternal and Child Health Journal|August 29, 2012
Unintentional injury in early childhood: its relationship with childcare setting and providerChristopher S Davis, Sarah E Godfrey, Kristin M Rankin
Journal of Aging Research|July 18, 2020
Clinical Conditions of Hospitalized Older Adult Patients and Their Outcomes in a Regional Referral Hospital in Southwestern UgandaPatrick Orikiriza, Godfrey Z Rukundo, Adrian Kayanja, et al.
Contraception|October 10, 2012
Treatment of unscheduled bleeding in women using extended- or continuous-use combined hormonal contraception: a systematic reviewEmily M Godfrey, Maura K Whiteman, Kathryn M Curtis
Dermatology Online Journal|October 31, 2025
Cutaneous metastasis of high-grade serous adenocarcinoma secondary to a gynecological malignancyStephanie Farrugia, David Pisani, Michael J Boffa, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|October 1, 2025
Retreatment TB is a risk factor for multidrug-resistant TB among people with HIV in rural eastern Uganda: A nested case-control studyGodfrey Opolot, Peter Olupot-Olupot, Samuel Okware, et al.
African Journal of Emergency Medicine : Revue Africaine De La Medecine D'Urgence|May 17, 2021
Observed benefits of a major trauma centre in a tertiary hospital in NigeriaUsman Adamu Gwaram, Onyedika Godfrey Okoye, Oluwole Olayemi Olaomi
Melanoma Research|December 10, 2024
Neurologic adverse events associated with BRAF and MEK inhibitor therapy in patients with malignant melanoma: a disproportionality analysis using the Food and Drug Administration Adverse Event Reporting SystemZachary Leibovit-Reiben, Hannah Godfrey, Patrick Jedlowski, et al.
Pageof 904